Shanghai KangaBio Co., Ltd.
Industry
- Biotechnology
- Pharmaceuticals
See more in Biomedtracker
Latest on Shanghai KangaBio Co., Ltd.
Scrip
• By Dexter Jie Yan
Chinese biotech financings worth roughly $100m or more and supported by venture capital and private equity firms have staged a comeback over the past month, while investors moved to make big bets on n
Scrip
• By Joseph Haas and Mandy Jackson
Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. PhoreMost To Deploy SITESEEKER Platform